246 related articles for article (PubMed ID: 25846716)
1. Clinical presentation of human C1q deficiency: How much of a lupus?
Stegert M; Bock M; Trendelenburg M
Mol Immunol; 2015 Sep; 67(1):3-11. PubMed ID: 25846716
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH
Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
[TBL] [Abstract][Full Text] [Related]
3. Marked variability in clinical presentation and outcome of patients with C1q immunodeficiency.
van Schaarenburg RA; Schejbel L; Truedsson L; Topaloglu R; Al-Mayouf SM; Riordan A; Simon A; Kallel-Sellami M; Arkwright PD; Åhlin A; Hagelberg S; Nielsen S; Shayesteh A; Morales A; Tam S; Genel F; Berg S; Ketel AG; Merlijn van den Berg J; Kuijpers TW; Olsson RF; Huizinga TW; Lankester AC; Trouw LA
J Autoimmun; 2015 Aug; 62():39-44. PubMed ID: 26119135
[TBL] [Abstract][Full Text] [Related]
4. Monogenic interferonopathies: Phenotypic and genotypic findings of CANDLE syndrome and its overlap with C1q deficient SLE.
Al-Mayouf SM; AlSaleem A; AlMutairi N; AlSonbul A; Alzaid T; Alazami AM; Al-Mousa H
Int J Rheum Dis; 2018 Jan; 21(1):208-213. PubMed ID: 29115062
[TBL] [Abstract][Full Text] [Related]
5. Hereditary C1q deficiency and systemic lupus erythematosus.
Bowness P; Davies KA; Norsworthy PJ; Athanassiou P; Taylor-Wiedeman J; Borysiewicz LK; Meyer PA; Walport MJ
QJM; 1994 Aug; 87(8):455-64. PubMed ID: 7922299
[TBL] [Abstract][Full Text] [Related]
6. Family study of natural killer cell activity in C1q-deficient patients with systemic lupus erythematosus-like syndrome: association between impaired natural killer cell function and C1q deficiency.
Tóth J; Starsia Z; Buc M; Stefanovic J
Immunobiology; 1989 Nov; 180(1):47-54. PubMed ID: 2625354
[TBL] [Abstract][Full Text] [Related]
7. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
8. Impact of C1q deficiency on the severity and outcome of childhood systemic lupus erythematosus.
Al-Mayouf SM; Abanomi H; Eldali A
Int J Rheum Dis; 2011 Feb; 14(1):81-5. PubMed ID: 21303486
[TBL] [Abstract][Full Text] [Related]
9. Systemic lupus erythematosus with C1q deficiency: treatment with fresh frozen plasma.
Ekinci Z; Ozturk K
Lupus; 2018 Jan; 27(1):134-138. PubMed ID: 29113537
[TBL] [Abstract][Full Text] [Related]
10. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
11. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
Martens HA; Zuurman MW; de Lange AH; Nolte IM; van der Steege G; Navis GJ; Kallenberg CG; Seelen MA; Bijl M
Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288
[TBL] [Abstract][Full Text] [Related]
12. Performance of the 2012 Systemic Lupus International Collaborating Clinics and the 1997 American College of Rheumatology classification criteria for systemic lupus erythematosus in a real-life scenario.
Amezcua-Guerra LM; Higuera-Ortiz V; Arteaga-García U; Gallegos-Nava S; Hübbe-Tena C
Arthritis Care Res (Hoboken); 2015 Mar; 67(3):437-41. PubMed ID: 25073545
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
[TBL] [Abstract][Full Text] [Related]
14. [Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab].
Tsanyan ME; Torgashina AV; Aleksandrova EN; Soloviev SK; Nasonov EL
Ter Arkh; 2013; 85(5):53-9. PubMed ID: 23819340
[TBL] [Abstract][Full Text] [Related]
15. Survey of Turkish systemic lupus erythematosus patients for a particular mutation of C1Q deficiency.
Topaloglu R; Bakkaloglu A; Slingsby JH; Aydintug O; Besbas N; Saatci U; Walport MJ
Clin Exp Rheumatol; 2000; 18(1):75-7. PubMed ID: 10728448
[TBL] [Abstract][Full Text] [Related]
16. Hereditary C1q deficiency: a new family with C1qA deficiency.
Sun-Tan C; Ozgür TT; Kilinç G; Topaloğlu R; Gököz O; Ersoy-Evans S; Sanal O
Turk J Pediatr; 2010; 52(2):184-6. PubMed ID: 20560256
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P
J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
[TBL] [Abstract][Full Text] [Related]
18. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
[TBL] [Abstract][Full Text] [Related]
19. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.
Mok CC; Ho LY; Leung HW; Wong LG
Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493
[TBL] [Abstract][Full Text] [Related]
20. Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency.
Jönsson G; Sjöholm AG; Truedsson L; Bengtsson AA; Braconier JH; Sturfelt G
Rheumatology (Oxford); 2007 Jul; 46(7):1133-9. PubMed ID: 17478473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
